hyfc EPO (long acting)

hyfc EPO (long acting)
Product Description

Efesa, is a long-acting Erythropoietin indicated for CKD-induced anemia in dialysis and non-dialysis patients. Efesa is a hybrid Fc of IgG4 and IgD that provides hinge flexibility and long serum half-life without causing toxicity to target cells. Global Phase 3 trial for non-dialysis indication is currently still ongoing and CSR is expected to be completed in Q3 2023. Interim results showed that Efesa has a non-inferior efficacy compared to Mircera without serious safety issues.

Kalbe

  • ID
  • 2018
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Contract Manufacturer
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
Natural Extracts
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Specifications
  • Selling Points
    Product Features; Product Performance

Kalbe

  • ID
  • 2018
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Contract Manufacturer
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
Natural Extracts
Out-licensing specialist
Pharmaceutical Company (generic finished products)

More Products from Kalbe (14)

  • Nephrisol

    Product Nephrisol

    Nephrisol is a specialized nutrition formulated to meet requirements for those with renal insufficiency, help delay CKD progression for patients on pre-dialysis stage.
    Nephrisol contains low protein amount, completed with 9 essentials amino acids (High Biological Value Protein), and completed with 12 ...
  • Nephrisol-D

    Product Nephrisol-D

    Nephrisol-D is a specialized nutrition formulated to meet the requirements for those with renal insufficiency in dialysis stage, to replenish protein loss during dialysis and prevent malnutrition.

    Nephrisol-D contains high protein amount, completed with 9 essentials amino acids (High B...
  • Nutrican

    Product Nutrican

    Nutrican is a special nutrition with high energy for patient with special nutrition needs to help prevent severe weight loss (cachexia) in chronic disease patient, such as cancer.

    Nutrican contains high energy and high protein amount, completed with specific nutrients such as Omega 3 (...
  • Peptibren

    Product Peptibren

    Peptibren is a special nutrition with high energy for patient with special nutrition needs to improve brain health and prevent malnutrition.

    Peptibren contains high protein amount, completed with specific nutrients such as Choline, Phosphatidylserine, and Nucleotide
  • Peptisol

    Product Peptisol

    Peptisol is a special nutrition with high protein to support increasing protein needs. Protein is an important macronutrient required especially in conditions such as post surgical recovery and convalescence.

  • Pulmosol

    Product Pulmosol

    Pulmosol is a specialized nutrition formulated to meet requirements for those with pulmonary disease.

    Pulmosol contains high protein, low carbohydrate, BCAAs (Branched Chain Amino Acids), Omega–3,  Glutamine, Inulin, vitamins and minerals.

  • Nimotuzumab

    Product Nimotuzumab

    Nimotuzumab binds with intermediate affinity and high specificity to the extracellular domain of EGFR and blocks the binding of the EGF to its receptor and inhibits tumor cell growth. The molecule induces cell lysis through ADCC mechanism. Nimotuzumab provides vaccinal effect that induce memory T-cell ...
  • Insulin Glargine

    Product Insulin Glargine

    Long-acting basal insulin analogue to treat Type I and II Diabetes Mellitus.
  • Erythropoietin Alpha

    Product Erythropoietin Alpha

    Indication: Chronic kidney diseases induced anemia (dialysis and non-dialysis)

  • Bevacizumab

    Product Bevacizumab

    Bevacizumab acts by selectively binding circulating VEGF, thereby inhibiting the binding of VEGF to its cell surface receptors. This inhibition leads to a reduction in microvascular growth of tumor blood vessels that limits the blood supply to tumor tissues.The indication is for Colorectal Cancer...
  • Trastuzumab

    Product Trastuzumab

    Trastuzumab binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2) and inhibits HER2 homodimerization, thereby preventing HER2-mediated signaling. The indication is for HER2 Triple Positive and HER2+ Gastric Cancer / Gastroesophageal Junction cancer.

  • Rituximab

    Product Rituximab

    Rituximab binds itself to the CD20 protein, marking them, and subsequently triggering the cells of the immune system to pick out the marked cells and kill them.The indication is for Non Hodgkin Lymphoma